corporary

BRAINEVER

Active
SIREN 810542506 VAT number FR05810542506

Business purpose.

Tant en France qu'à l'étranger: la recherche, le développement et la commercialisation de traitements thérapeutique des pathologies du système nerveux central; la création, l'acquisition, la location, la prise en location-gérance de tous fonds de commerce, la prise à bail, l'installation de tous établissements, fonds de commerce, usines ateliers, se rapportant à l'une ou l'autre des activités spécifiées; la prise, l'acquisition, l'exploitation ou la cession de tous procédés ou brevets concernant ces activités. La participation directe ou indirecte de la société dans toutes opérations financières, immobilières, ou mobilières et dans toutes entreprises commerciales ou industrielles pouvant se rattacher à l'objet social ou à tout objet similaire ou connexe de nature à favoriser son extension ou son développement.

Identity

Legal form
SAS, simplified joint-stock company
Activity
Research and experimental development on biotechnology (72.11Z)
Sector
Scientific research and development
Headcount
10 to 19 employees
Created
26 Mar 2015
Share capital
60,269.02 EUR
Registered with the trade register
31 Mar 2015
Financial year end
31/12
Establishments
1

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

274 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

21 / 100 E

Confidence: medium · computed on the financial year ended 31 Dec 2024

Equity to assets (-30.9 %)
0.0 out of 30
EBITDA margin (-208.3 %)
0.0 out of 25
Liquidity (101.3 %)
3.6 out of 20
Debt (-109.6 %)
15.0 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

100 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (11.7 years)
20.0 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2016 2017 2018 2019 2020 2021 2022 2023 2024

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2024 0 € — -2,835,459 € -2,076,532 €
31 Dec 2023 0 € — -4,913,537 € -4,618,693 €
31 Dec 2022 0 € — -6,206,005 € -4,576,216 €
31 Dec 2021 0 € — -5,446,153 € -3,935,308 €
31 Dec 2020 0 € — -4,443,307 € -3,171,639 €
31 Dec 2019 0 € — -5,187,613 € -4,106,201 €
31 Dec 2018 0 € — -3,704,432 € -2,945,437 €
31 Dec 2017 0 € — -1,361,560 € -1,028,120 €
31 Dec 2016 0 € first year on record -648,187 € -667,295 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Collective agreements

Agreements declared by the employer in its payroll filings.

  • Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.

    IDCC 0176 · repealed · 1 establishment · declared in August 2026

Legal notices

  • Amendment 19 Jun 2026
    Court :
    Greffe du Tribunal des Activités Economiques de Paris
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20260115, annonce n 2295 · Proof of publication (PDF)

  • Amendment 10 Feb 2026
    Court :
    Greffe du Tribunal des Activités Economiques de Paris
    Amendment :
    modification survenue sur le capital (augmentation) et l'administration

    BODACC B n 20260027, annonce n 5587 · Proof of publication (PDF)

  • Filing of accounts 3 Sep 2025
    Court :
    Greffe du Tribunal des Activités Economiques de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250168, annonce n 4669 · Proof of publication (PDF)

  • Amendment 21 May 2025
    Court :
    Greffe du Tribunal des Activités Economiques de Paris
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20250097, annonce n 1447 · Proof of publication (PDF)

  • Amendment 2 Oct 2024
    Court :
    Greffe du Tribunal de Commerce de Paris
    Amendment :
    modification survenue sur le capital (augmentation) et l'administration

    BODACC B n 20240191, annonce n 1891 · Proof of publication (PDF)

  • Filing of accounts 12 Sep 2024
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20240177, annonce n 7393 · Proof of publication (PDF)

  • Filing of accounts 27 Feb 2024
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2022

    BODACC C n 20240040, annonce n 4270 · Proof of publication (PDF)

  • Filing of accounts 21 Feb 2024
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2022

    BODACC C n 20240036, annonce n 3842 · Proof of publication (PDF)

  • Filing of accounts 23 Aug 2022
    Court :
    Greffe du Tribunal de Commerce de paris
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2021

    BODACC C n 20220162, annonce n 3898 · Proof of publication (PDF)

  • Filing of accounts 17 Aug 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2020

    BODACC C n 20210159, annonce n 4588 · Proof of publication (PDF)

  • Amendment 12 Aug 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20210156, annonce n 2136 · Proof of publication (PDF)

  • Filing of accounts 19 Nov 2020
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2019

    BODACC C n 20200225, annonce n 12381 · Proof of publication (PDF)

  • Amendment 23 Oct 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Amendment :
    modification survenue sur le capital (augmentation)

    BODACC B n 20190205, annonce n 1152 · Proof of publication (PDF)

  • Amendment 16 Aug 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Amendment :
    modification survenue sur l'administration

    BODACC B n 20190157, annonce n 2129 · Proof of publication (PDF)

  • Filing of accounts 9 Aug 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE PARIS
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2018

    BODACC C n 20190153, annonce n 5373 · Proof of publication (PDF)

Filings and annual accounts as PDF →

Filings and accounts

  • Formality 30 Jan 2026
  • Formality 12 May 2025

Change history

  • Appointed: Administrateur 9 Oct 2026
  • Appointed: Administrateur 9 Oct 2026
  • Appointed: Administrateur 9 Oct 2026
  • Appointed: Commissaire aux comptes titulaire 9 Oct 2026
  • Appointed: Administrateur 9 Oct 2026
  • Appointed: President de SAS 9 Oct 2026
  • Share capital changed from 21,400 € to 38,500 € 3 Oct 2026
  • Share capital changed from 38,500 € to 21,400 € 3 Oct 2026
  • Share capital changed from 47,329 € to 38,500 € 3 Oct 2026
  • Share capital changed from 49,019.02 € to 47,329 € 2 Oct 2026
  • Share capital changed from 70,269.02 € to 49,019.02 € 2 Oct 2026
  • Registered office: 74 rue du Faubourg Saint-Antoine 75012 Paris 1 Oct 2026
  • Share capital changed from 60,269.02 € to 70,269.02 € 1 Oct 2026
  • Share capital: 60,269.02 € 1 Oct 2026

Frequently asked questions about BRAINEVER

What is the SIREN number of BRAINEVER?
The SIREN number of BRAINEVER is 810542506. Its intra-community VAT number is FR05810542506.
Where is the head office of BRAINEVER?
Head office address: 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12.
When was BRAINEVER founded?
BRAINEVER was founded on 26 Mar 2015.
What does BRAINEVER do?
Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
Who runs BRAINEVER?
The officers listed in the register are ALAIN LOUIS Prochiantz (Administrateur), BJ HOLDING (Administrateur), LNE SM HOLDING (Administrateur).
What is the revenue of BRAINEVER?
The latest published revenue is 0 €, for the 2024 financial year.
How many employees does BRAINEVER have?
The declared headcount is 10 to 19 employees. Insee data for 2024.
Is BRAINEVER subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data